“Multiplexed viability, cytotoxicity, and caspase activity assays”

Methods in Molecular Biology

Volumn 1219, Issue , 2015, Pages 21-33

  Niles, Andrew L ^a   Riss, Terry L ^a  

^a NONE

Author keywords

Caspase; Cell based; Cytotoxicity; Fluorescence; Luminescence; Multiplex

Indexed keywords

APOPTOSIS; ARTICLE; ASSAY; CASPASE ACTIVITY ASSAY; CASPASE ASSAY; CELL COUNT; CONTROLLED STUDY; CYTOTOXICITY ASSAY; FLUORESCENCE; FLUOROMETRY; LUMINESCENCE; MULTIPLEXED VIABILITY ASSAY; PRIORITY JOURNAL; ANIMAL; CULTURE TECHNIQUE; DEVICES; DRUG EFFECTS; ENZYME ACTIVATION; HUMAN; K562 CELL LINE; METABOLISM; MOLECULAR BIOLOGY; PROCEDURES; TOXICITY TESTING;

BORONIC ACID DERIVATIVE; BORTEZOMIB; CASPASE; PYRAZINE DERIVATIVE;

ANIMALS; APOPTOSIS; BORONIC ACIDS; CASPASES; CELL CULTURE TECHNIQUES; ENZYME ACTIVATION; HUMANS; K562 CELLS; MOLECULAR BIOLOGY; PYRAZINES; TOXICITY TESTS;

EID: 84955363001     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1661-0_3     Document Type: Article

References (15)

1. Grant S, Sklar J, Cummings R (2002) Development of novel assays for proteolytic enzymes using rhodamine-based substrates. J Biomol Screen 7:531–540
2. Bronstein I, Fortin J, Stanley PE, Stewart GSAB, Kricka LJ (1994) Chemiluminescent and bioluminescent reporter gene assays. Anal Biochem 219:169–181
3. Wesierska-Gadek J, Gueorguieva M, Ranftler C, Zerza-Schnitzhofer G (2005) A new multiplex assay allowing simultaneous detection of the inhibition of cell proliferation and induction of cell death. J Cell Biochem 96:1–7
4. Nieuwenhuijsen B, Huang Y, Wang Y, Ramerez F, Kalgaonkar G, Young K (2003) A dual luciferase multiplex high-throughput screening platform for protein-protein interactions. J Biomol Screen 8:676–684
5. Hook B, Schagat T (2012) Profi ling compound effects on cell health in a time course using a multiplexed, same-well assay. PubHub Online
6. Niles A, Worzella T, Zhou M, McDougall M, Lazar D (2012) Measuring cytotoxicity in real time with a highly stable green dye. [Internet] December 2012
7. Niles A, Moravec R, Riss T (2004) Characterizing responses to treatments using homogeneous caspase activity and cell viability assays. Cell Notes 9:11–14
8. Niles A, Worzela T, Scurria M, Daily W, Bernad L, Guthmiller P, McNamara B, Rashka K, Lange D, Riss T (2006) Multiplexed viability, cytotoxicity and apoptosis assays for cell-based screening. Cell Notes 16:12–15
9. Niles A, Moravec R, Riss T (2008) Update on in vitro cytotoxicity assays for drug development. Expert Opin Drug Discov 3:655–669
10. Leist M, Jaattela M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Biol 2:1–10
11. Worzella T et al (2013) Real-time cytotoxicity analysis using CellTox™ green cytotoxicity assay and the Tecan Infi nite ® 200 PRO with gas control module. [Internet] May 2013
12. Caraglia M, Santini D, Marra M, Vincenzi B, Tonini G, Budillon A (2006) Emerging anticancer molecular mechanisms of aminobisphosphonates. Endocr Relat Cancer 13:7–26
13. Hook B, Bratz M, Schagat T (2013) Gain more informative data by multiplexing a fl uorescent real-time cytotoxicity assay with luminescent, fl uorescent or colorimetric viability assays. [Internet] June 2013
14. Niles A, Moravec R, Hesselberth P, Scurria M, Daily W, Riss T (2007) A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers. Anal Biochem 366:197–206
15. Riss T, Moravec R (2004) Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cellbased assays. Assay Drug Dev Technol 2:51–62